The Valley Desk

ArticleAnnals of the rheumatic diseasesPublished

Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Annals of the rheumatic diseases
Published
Subject terms
Humans; Sjogren's Syndrome; Hydroxychloroquine; Antirheumatic Agents; Treatment Outcome; Drug Therapy, Combination; Adult; Aged; Middle Aged; Female; Male; Randomized Controlled Trials as Topic
PubMed ID
41448992
Added to directory
Source checked

Report a correction or request removal